» Authors » Terho Heikkinen

Terho Heikkinen

Explore the profile of Terho Heikkinen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 96
Citations 3153
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Johannesen C, Gideonse D, Osei-Yeboah R, Lehtonen T, Jollivet O, Cohen R, et al.
Lancet Reg Health Eur . 2025 Feb; 51:101227. PMID: 39995488
Background: Respiratory syncytial virus (RSV) can cause severe disease, notably among infants, older adults, and individuals with comorbidities. Non-systematic testing and differences in coding practices affect direct measures of the...
2.
Zhao C, Zhang T, Guo L, Sun S, Miao Y, Yung C, et al.
Nat Commun . 2025 Feb; 16(1):1610. PMID: 39948338
The COVID-19 pandemic and relevant non-pharmaceutical interventions (NPIs) interrupted the circulation of common respiratory viruses. These viruses demonstrated an unprecedented asynchronous resurgence as NPIs were relaxed. We compiled a global...
3.
Kristensen M, de Steenhuijsen Piters W, Wildenbeest J, van Houten M, Zuurbier R, Hasrat R, et al.
Cell Rep Med . 2024 Dec; 5(12):101836. PMID: 39642873
Respiratory syncytial virus (RSV) is the leading cause of infant respiratory infections and hospitalizations. To investigate the relationship between the respiratory microbiome and RSV infection, we sequence nasopharyngeal samples from...
4.
Harding E, Wildenbeest J, Heikkinen T, Dacosta-Urbieta A, Martinon-Torres F, Cunningham S, et al.
J Infect Dis . 2024 Jun; 230(5):e985-e995. PMID: 38912724
Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic disrupted respiratory syncytial virus (RSV) seasonality. To optimize the use and evaluation of RSV infant immunization strategies, monitoring changes in...
5.
Langedijk A, Vrancken B, Lebbink R, Wilkins D, Kelly E, Baraldi E, et al.
Nat Commun . 2024 Apr; 15(1):3083. PMID: 38600104
Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infection in young children and the second leading cause of infant death worldwide. While global circulation has...
6.
Uusitupa E, Waris M, Vuorinen T, Heikkinen T
Influenza Other Respir Viruses . 2024 Mar; 18(3):e13268. PMID: 38477388
Background: The risk of respiratory syncytial virus (RSV) hospitalization is highest during the first months of life, but few studies have assessed the population-based rates of hospitalization in monthly age...
7.
Hak S, Venekamp R, Billard M, van Houten M, Pollard A, Heikkinen T, et al.
J Infect Dis . 2024 Mar; 229(Supplement_1):S40-S50. PMID: 38424744
Background: During the first year of life, 1 in 4 infants develops a symptomatic respiratory syncytial virus (RSV) infection, yet only half seek medical attention. The current focus on medically...
8.
Wang X, Li Y, Shi T, Bont L, Chu H, Zar H, et al.
Lancet . 2024 Feb; 403(10433):1241-1253. PMID: 38367641
Background: Infants and young children born prematurely are at high risk of severe acute lower respiratory infection (ALRI) caused by respiratory syncytial virus (RSV). In this study, we aimed to...
9.
Cong B, Koc U, Bandeira T, Bassat Q, Bont L, Chakhunashvili G, et al.
Lancet Infect Dis . 2023 Dec; 24(4):361-374. PMID: 38141633
Background: The COVID-19 pandemic is reported to have affected the epidemiology of respiratory syncytial virus (RSV), which could have important implications for RSV prevention and control strategies. We aimed to...
10.
van Roekel C, Poukka E, Turunen T, Nohynek H, Presser L, Meijer A, et al.
J Infect Dis . 2023 Nov; 229(Supplement_1):S92-S99. PMID: 37935046
Monitoring the real-life effectiveness of respiratory syncytial virus (RSV) products is of major public health importance. This generic protocol for a test-negative design study aims to address currently envisioned approaches...